FLJ10540 is associated with tumor progression in nasopharyngeal carcinomas and contributes to nasopharyngeal cell proliferation, and metastasis via osteopontin/CD44 pathway

Journal of Translational Medicine

Volumn 10, Issue 1, 2012, Pages

  Chen, Chang Han ^a,b   Shiu, Li Yen ^c   Su, Li Jen ^d   Huang, Chi Ying F ^e   Huang, Shun Chen ^b   Huang, Chao Cheng ^a,b   Yin, Yu Fang ^a,b   Wang, Wei Sheng ^a,b   Tsai, Hsin Ting ^a,b   Fang, Fu Min ^a,b   Chuang, Wan Chu ^a,b   Kang, Hong Chang ^a,b   Hwang, Chung Feng ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG BING SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

CD44; FLJ10540; Nasopharyngeal carcinoma; Osteopontin

Indexed keywords

HERMES ANTIGEN; MESSENGER RNA; OSTEOPONTIN; PROTEIN FLJ10540; SMALL INTERFERING RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; CEP55 PROTEIN, HUMAN; NUCLEAR PROTEIN;

ADULT; ADVANCED CANCER; ARTICLE; BIOINFORMATICS; CANCER STAGING; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN HONE1; CELL STRAIN TW01; CONTROLLED STUDY; FEMALE; FLJ10540 GENE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STABLE TRANSFECTION; SURVIVAL RATE; TUMOR GROWTH; CANCER INVASION; CELL MOTION; CHI SQUARE DISTRIBUTION; DISEASE COURSE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; METASTASIS; NASOPHARYNX; NASOPHARYNX TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL; TUMOR CELL LINE; TUMOR GENE; UPREGULATION;

CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; OSTEOPONTIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TRANSFECTION; UP-REGULATION;

EID: 84860998892     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-10-93     Document Type: Article

References (34)

1. Zeng ZY, Zhou YH, Zhang WL, Xiong W, Fan SQ, Li XL, Luo XM, Wu MH, Yang YX, Huang C, Cao L, Tang K, Qian J, Shen SR, Li GY. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 2007, 38:120-133. 10.1016/j.humpath.2006.06.023, 16996564.
2. Brennan B. Nasopharyngeal carcinoma. Orphanet J Rare Dis 2006, 1:23. 10.1186/1750-1172-1-23, 1559589, 16800883.
3. Fang FM, Tsai WL, Go SF, Ho MW, Wu JM, Wang CJ, Su CY, Chen WC, Huang EY. Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of radiotherapy. Int J Radiat Oncol Biol Phys 2001, 50:961-969. 10.1016/S0360-3016(01)01531-0, 11429224.
4. Hwang CF, Chien CY, Huang SC, Yin YF, Huang CC, Fang FM, Tsai HT, Su LJ, Chen CH. Fibulin-3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity. J Pathol 2010, 222:367-379. 10.1002/path.2776, 20927779.
5. Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003, 3:55-63. 10.1038/nrc967, 12509767.
6. Zhou HY, Wan KF, Ip CK, Wong CK, Mak NK, Lo KW, Wong AS. Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK. FEBS Lett 2008, 582:3415-3422. 10.1016/j.febslet.2008.09.004, 18789327.
7. Chong VF, Ong CK. Nasopharyngeal carcinoma. Eur J Radiol 2008, 66:437-447. 10.1016/j.ejrad.2008.03.029, 18485650.
8. Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM. Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis. Head Neck 2008, 30:946-963. 10.1002/hed.20833, 3046044, 18446839.
9. Du ZM, Hu CF, Shao Q, Huang MY, Kou CW, Zhu XF, Zeng YX, Shao JY. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients. Int J Cancer 2009, 125:1832-1841. 10.1002/ijc.24531, 19582878.
10. Ishijima M, Rittling SR, Yamashita T, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M. Enhancement of osteoclastic bone resorption and suppression of osteoblastic bone formation in response to reduced mechanical stress do not occur in the absence of osteopontin. J Exp Med 2001, 193:399-404. 10.1084/jem.193.3.399, 2195919, 11157060.
11. Christensen B, Petersen TE, Sorensen ES. Post-translational modification and proteolytic processing of urinary osteopontin. Biochem J 2008, 411:53-61. 10.1042/BJ20071021, 18072945.
12. Wimmer N, Robinson JA, Gopisetty-Venkata N, Roberts-Thomson SJ, Monteith GR, Toth I. Anti-proliferative effects of novel glyco-lipid-arsenicals (III) on MCF-7 human breast cancer cells. Med Chem 2006, 2:79-87. 10.2174/157340606775197714, 16787358.
13. Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, McCulloch CA, Sodek J. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J Cell Physiol 2004, 198:155-167. 10.1002/jcp.10394, 14584055.
14. Anborgh PH, Mutrie JC, Tuck AB, Chambers AF. Pre- and post-translational regulation of osteopontin in cancer. J Cell Commun Signal 2011, 5:111-122. 10.1007/s12079-011-0130-6, 3088790, 21516514.
15. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF, Yeatman TJ. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 2004, 10:184-190. 10.1158/1078-0432.CCR-1405-2, 14734468.
16. Forootan SS, Foster CS, Aachi VR, Adamson J, Smith PH, Lin K, Ke Y. Prognostic significance of osteopontin expression in human prostate cancer. Int J Cancer 2006, 118:2255-2261. 10.1002/ijc.21619, 16331611.
17. Chen RX, Xia YH, Xue TC, Zhang H, Ye SL. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA. Oncol Rep 2011, 25:803-808.
18. Gonzalez-Cid M, Fundia AF, Cuello MT, Larripa I. Correlation between chromosome damage and apoptosis induced by fludarabine and idarubicin in normal human lymphocytes. Toxicology 2002, 171:215-222. 10.1016/S0300-483X(01)00596-0, 11836027.
19. Fabbro M, Zhou BB, Takahashi M, Sarcevic B, Lal P, Graham ME, Gabrielli BG, Robinson PJ, Nigg EA, Ono Y, Khanna KK. Cdk1/Erk2- and Plk1-dependent phosphorylation of a centrosome protein, Cep55, is required for its recruitment to midbody and cytokinesis. Dev Cell 2005, 9:477-488. 10.1016/j.devcel.2005.09.003, 16198290.
20. Sakai M, Shimokawa T, Kobayashi T, Matsushima S, Yamada Y, Nakamura Y, Furukawa Y. Elevated expression of C10orf3 (chromosome 10 open reading frame 3) is involved in the growth of human colon tumor. Oncogene 2006, 25:480-486.
21. Chen CH, Lu PJ, Chen YC, Fu SL, Wu KJ, Tsou AP, Lee YC, Lin TC, Hsu SL, Lin WJ, Huang CY, Chou CK. FLJ10540-elicited cell transformation is through the activation of PI3-kinase/AKT pathway. Oncogene 2007, 26:4272-4283. 10.1038/sj.onc.1210207, 17237822.
22. Chen CH, Lai JM, Chou TY, Chen CY, Su LJ, Lee YC, Cheng TS, Hong YR, Chou CK, Whang-Peng J, Wu YC, Huang CY. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway. PLoS One 2009, 4:e5052. 10.1371/journal.pone.0005052, 2659802, 19337377.
23. Chen CH, Chien CY, Huang CC, Hwang CF, Chuang HC, Fang FM, Huang HY, Chen CM, Liu HL, Huang CY. Expression of FLJ10540 is correlated with aggressiveness of oral cavity squamous cell carcinoma by stimulating cell migration and invasion through increased FOXM1 and MMP-2 activity. Oncogene 2009, 28:2723-2737. 10.1038/onc.2009.128, 19525975.
24. Chen CH, Su CY, Chien CY, Huang CC, Chuang HC, Fang FM, Huang HY, Chen CM, Chiou SJ. Overexpression of beta2-microglobulin is associated with poor survival in patients with oral cavity squamous cell carcinoma and contributes to oral cancer cell migration and invasion. Br J Cancer 2008, 99:1453-1461. 10.1038/sj.bjc.6604698, 2579697, 18841160.
25. Cho H, Hong SW, Oh YJ, Kim MA, Kang ES, Lee JM, Kim SW, Kim SH, Kim JH, Kim YT, Lee K. Clinical significance of osteopontin expression in cervical cancer. J Cancer Res Clin Oncol 2008, 134:909-917. 10.1007/s00432-007-0351-5, 18210151.
26. Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, Hsu MM, Chuang SM. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest 1990, 62:713-724.
27. Lin CT, Chan WY, Chen W, Huang HM, Wu HC, Hsu MM, Chuang SM, Wang CC. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 1993, 68:716-727.
28. Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS, Li YP. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci U S A 1989, 86:9524-9528. 10.1073/pnas.86.23.9524, 298529, 2556716.
29. Sengupta S, den Boon JA, Chen IH, Newton MA, Dahl DB, Chen M, Cheng YJ, Westra WH, Chen CJ, Hildesheim A, Sugden B, Ahlquist P. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res 2006, 66:7999-8006. 10.1158/0008-5472.CAN-05-4399, 16912175.
30. Niehrs C, Pollet N. Synexpression groups in eukaryotes. Nature 1999, 402:483-487.
31. Yoshizaki T. Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1. Histol Histopathol 2002, 17:845-850.
32. Kolb A, Kleeff J, Guweidhi A, Esposito I, Giese NA, Adwan H, Giese T, Buchler MW, Berger MR, Friess H. Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions. Cancer Biol Ther 2005, 4:740-746. 10.4161/cbt.4.7.1821, 15970685.
33. Celetti A, Testa D, Staibano S, Merolla F, Guarino V, Castellone MD, Iovine R, Mansueto G, Somma P, De Rosa G, Galli V, Melillo RM, Santoro M. Overexpression of the cytokine osteopontin identifies aggressive laryngeal squamous cell carcinomas and enhances carcinoma cell proliferation and invasiveness. Clin Cancer Res 2005, 11:8019-8027. 10.1158/1078-0432.CCR-05-0641, 16299231.
34. Lin YH, Yang-Yen HF. The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem 2001, 276:46024-46030. 10.1074/jbc.M105132200, 11590166.